The purpose of this research study is to evaluate the effectiveness of the study product on vasomotor symptoms (VMS) and overall menopause symptoms in healthy women, who are perimenopausal or postmenopausal, and aged 40 - 65.
Age range
40 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
To determine the effects of the Study Product (SP) compared to placebo on hot flash symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on hot flash symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on hot flash symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on vasomotor symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on overall menopausal symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on overall menopausal symptoms
Timeframe: 12 weeks
To determine the effects of the SP compared to placebo on quality of life
Timeframe: 12 weeks